KALA BIO, Inc.KALAEarnings & Financial Report
Nasdaq
KALA Q4 2022 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-10.3M
Net Profit
$-12.8M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-47.90
KALA BIO, Inc. Q4 2022 Financial Summary
KALA BIO, Inc. reported revenue of $0 for Q4 2022, with a net profit of $-12.8M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-12.8M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q4 2022 |
KALA BIO, Inc. Annual Revenue by Year
KALA BIO, Inc. annual revenue history includes year-by-year totals (for example, 2022 revenue was $3.9M).
| Year | Annual Revenue |
|---|---|
| 2022 | $3.9M |
Income Statement
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Revenue | $1.4M | $2.1M | $420000 | $0 |
| YoY Growth | -58.0% | -31.2% | -86.3% | N/A |
Balance Sheet
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Assets | $111.6M | $85.0M | $85.7M | $86.8M |
| Liabilities | $116.9M | $116.5M | $86.7M | $67.8M |
| Equity | $-5.3M | $-31.6M | $-968000 | $19.0M |
Cash Flow
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | |
|---|---|---|---|---|
| Operating CF | $-24.1M | $-25.4M | $-15.7M | $-13.7M |